These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

805 related items for PubMed ID: 18661452

  • 1. [Comments by the Working Group for Methods of Economic Evaluation in Health Care (AG MEG) to IQWiG's Draft Guidelines "Methods for Assessment of the Relation of Benefits to Costs in the German Statutory Health Care System"].
    Krauth C, John J, Aidelsburger P, Brüggenjürgen B, Hansmeier T, Hessel F, Kohlmann T, Moock J, Rothgang H, Schweikert B, Seitz R, Wasem J, AG Methoden der gesundheitsökonomischen Evaluation.
    Gesundheitswesen; 2008 Jun; 70(6):e1-16. PubMed ID: 18661452
    [Abstract] [Full Text] [Related]

  • 2. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE, Kleijnen J.
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Decision-analytical modelling of costs per QALY in the context of the German Social Law].
    Rogowski WH, Landauer M, John J.
    Gesundheitswesen; 2009 Nov; 71(11):739-50. PubMed ID: 19551622
    [Abstract] [Full Text] [Related]

  • 5. [Experiences with and impact of health technology assessment on the German Standing Committee of physicians and patients].
    Gibis B, Rheinberger P.
    Z Arztl Fortbild Qualitatssich; 2002 Feb; 96(2):82-90. PubMed ID: 11921610
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of the National Institute for Health and Clinical Excellence's technology appraisals on prescribing and net ingredient costs of drugs in the National Health Service in England.
    Dietrich ES.
    Int J Technol Assess Health Care; 2009 Jul; 25(3):262-71. PubMed ID: 19619344
    [Abstract] [Full Text] [Related]

  • 9. [Drug assessment: IQWiG, G-BA, and an international comparison].
    Glaeske G.
    Internist (Berl); 2016 Jan; 57(1):94-101. PubMed ID: 26502888
    [Abstract] [Full Text] [Related]

  • 10. [Cost-effectiveness evaluation of drugs: multidisciplinary collaboration and transparency are key].
    Mueller EA, Kirch W.
    Med Klin (Munich); 2008 Oct 15; 103(10):712-6. PubMed ID: 18936896
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The efficiency frontier approach to economic evaluation of health-care interventions.
    Caro JJ, Nord E, Siebert U, McGuire A, McGregor M, Henry D, de Pouvourville G, Atella V, Kolominsky-Rabas P.
    Health Econ; 2010 Oct 15; 19(10):1117-27. PubMed ID: 20575151
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sins of omission and obfuscation: IQWIG's guidelines on economic evaluation methods.
    Sculpher M, Claxton K.
    Health Econ; 2010 Oct 15; 19(10):1132-6. PubMed ID: 20662107
    [No Abstract] [Full Text] [Related]

  • 18. [Economic and ethical aspects of the development of treatment guidelines].
    Lauterbach KW.
    Z Arztl Fortbild Qualitatssich; 1997 Jun 15; 91(3):277-82. PubMed ID: 9312433
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.